
CEBU, Philippines -- Malaysia's IHH Healthcare has led a $20-million Series A funding round for Singapore-based Lucence, the inventor of blood-based tests for cancer screening and treatment selection, the companies announced Wednesday.
Health care giant hopes to deploy liquid biopsy technology
CEBU, Philippines -- Malaysia's IHH Healthcare has led a $20-million Series A funding round for Singapore-based Lucence, the inventor of blood-based tests for cancer screening and treatment selection, the companies announced Wednesday.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.